OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
GELS Gelteq
- 1.040
- -0.010-0.95%
Close Mar 31 16:00 ET
9.82MMarket Cap-4.43P/E (TTM)
1.050High0.930Low35.62KVolume1.040Open1.050Pre Close35.28KTurnover1.17%Turnover RatioLossP/E (Static)9.44MShares5.50052wk High1.04P/B3.17MFloat Cap0.93052wk Low--Dividend TTM3.05MShs Float5.500Historical High--Div YieldTTM11.43%Amplitude0.930Historical Low0.990Avg Price1Lot Size
About Gelteq Company
Gelteq Ltd. is a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.
Company Profile
SymbolGELS
Company NameGelteq
Listing DateOct 29, 2024
Issue Price4.00
Founded2017
CEOMr. Nathan J. Givoni
MarketNASDAQ
Employees20
Fiscal Year Ends06-30
Address100 Albert Road,Level 4
CitySouth Melbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3025
Phone61-3-9087-3990
Websitehttp://www.gelteq.com
Company Executives
- Name
- Position
- Salary
- Nathan J. Givoni
- Director and Chief Executive Officer
- --
- Anthony W. Panther
- Chief Financial Officer and Principal Accounting Officer
- --
- Simon H. Szewach
- Executive Chairman of the Board
- --
- The Honourable Philip A. Dalidakis
- Independent Director
- --
- Professor David Morton
- Independent Director
- --
- Jeffrey W. Olyniec
- Independent Director
- --
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025